vs
AAON, INC.（AAON）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是AAON, INC.的1.5倍（$622.0M vs $424.2M），Royalty Pharma plc净利率更高（34.4% vs 7.6%，领先26.9%），AAON, INC.同比增速更快（42.5% vs 4.8%），过去两年AAON, INC.的营收复合增速更高（27.2% vs 4.6%）
AAON公司是商用及工业领域暖通空调设备专业生产商，总部位于美国俄克拉荷马州塔尔萨市，在得克萨斯州朗维尤、密苏里州帕克维尔、俄勒冈州雷德蒙德设有生产基地，全球员工约4000人，年销售额超8.8亿美元。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
AAON vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.5倍
$424.2M
营收增速更快
AAON
高出37.7%
4.8%
净利率更高
RPRX
高出26.9%
7.6%
两年增速更快
AAON
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $424.2M | $622.0M |
| 净利润 | $32.0M | $214.2M |
| 毛利率 | 25.9% | — |
| 营业利润率 | 10.4% | 62.4% |
| 净利率 | 7.6% | 34.4% |
| 营收同比 | 42.5% | 4.8% |
| 净利润同比 | 29.7% | 2.9% |
| 每股收益（稀释后） | $0.38 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AAONRPRX
| Q4 25 | $424.2M | $622.0M | ||
| Q3 25 | $384.2M | $609.3M | ||
| Q2 25 | $311.6M | $578.7M | ||
| Q1 25 | $322.1M | $568.2M | ||
| Q4 24 | $297.7M | $593.6M | ||
| Q3 24 | $327.3M | $564.7M | ||
| Q2 24 | $313.6M | $537.3M | ||
| Q1 24 | $262.1M | $568.0M |
净利润AAONRPRX
| Q4 25 | $32.0M | $214.2M | ||
| Q3 25 | $30.8M | $288.2M | ||
| Q2 25 | $15.5M | $30.2M | ||
| Q1 25 | $29.3M | $238.3M | ||
| Q4 24 | $24.7M | $208.2M | ||
| Q3 24 | $52.6M | $544.0M | ||
| Q2 24 | $52.2M | $102.0M | ||
| Q1 24 | $39.0M | $4.8M |
毛利率AAONRPRX
| Q4 25 | 25.9% | — | ||
| Q3 25 | 27.8% | — | ||
| Q2 25 | 26.6% | — | ||
| Q1 25 | 26.8% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 34.9% | — | ||
| Q2 24 | 36.1% | — | ||
| Q1 24 | 35.2% | — |
营业利润率AAONRPRX
| Q4 25 | 10.4% | 62.4% | ||
| Q3 25 | 11.3% | 70.1% | ||
| Q2 25 | 7.6% | 36.3% | ||
| Q1 25 | 10.9% | 94.0% | ||
| Q4 24 | 9.9% | 60.9% | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 21.4% | 50.2% | ||
| Q1 24 | 17.9% | -13.0% |
净利率AAONRPRX
| Q4 25 | 7.6% | 34.4% | ||
| Q3 25 | 8.0% | 47.3% | ||
| Q2 25 | 5.0% | 5.2% | ||
| Q1 25 | 9.1% | 41.9% | ||
| Q4 24 | 8.3% | 35.1% | ||
| Q3 24 | 16.1% | 96.3% | ||
| Q2 24 | 16.7% | 19.0% | ||
| Q1 24 | 14.9% | 0.8% |
每股收益（稀释后）AAONRPRX
| Q4 25 | $0.38 | $0.49 | ||
| Q3 25 | $0.37 | $0.67 | ||
| Q2 25 | $0.19 | $0.07 | ||
| Q1 25 | $0.35 | $0.55 | ||
| Q4 24 | $0.31 | $0.46 | ||
| Q3 24 | $0.63 | $1.21 | ||
| Q2 24 | $0.62 | $0.23 | ||
| Q1 24 | $0.46 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.0K | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $895.0M | $9.7B |
| 总资产 | $1.7B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资AAONRPRX
| Q4 25 | $13.0K | $618.7M | ||
| Q3 25 | $1.0M | $938.9M | ||
| Q2 25 | $14.0K | $631.9M | ||
| Q1 25 | $994.0K | $1.1B | ||
| Q4 24 | $14.0K | $929.0M | ||
| Q3 24 | $15.0K | $950.1M | ||
| Q2 24 | $13.0K | $1.8B | ||
| Q1 24 | $8.4M | $843.0M |
总债务AAONRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益AAONRPRX
| Q4 25 | $895.0M | $9.7B | ||
| Q3 25 | $863.1M | $9.6B | ||
| Q2 25 | $832.7M | $9.5B | ||
| Q1 25 | $815.9M | $9.8B | ||
| Q4 24 | $824.6M | $10.3B | ||
| Q3 24 | $796.9M | $10.3B | ||
| Q2 24 | $740.5M | $9.8B | ||
| Q1 24 | $784.8M | $9.9B |
总资产AAONRPRX
| Q4 25 | $1.7B | $19.6B | ||
| Q3 25 | $1.5B | $19.3B | ||
| Q2 25 | $1.4B | $18.3B | ||
| Q1 25 | $1.3B | $17.6B | ||
| Q4 24 | $1.2B | $18.2B | ||
| Q3 24 | $1.0B | $18.0B | ||
| Q2 24 | $1.0B | $17.7B | ||
| Q1 24 | $952.9M | $16.1B |
负债/权益比AAONRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.3M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.60× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AAONRPRX
| Q4 25 | $19.3M | $827.1M | ||
| Q3 25 | $12.3M | $702.6M | ||
| Q2 25 | $-21.8M | $364.0M | ||
| Q1 25 | $-9.2M | $596.1M | ||
| Q4 24 | $845.0K | $742.5M | ||
| Q3 24 | $63.8M | $703.6M | ||
| Q2 24 | $35.5M | $658.2M | ||
| Q1 24 | $92.4M | $664.6M |
现金转化率AAONRPRX
| Q4 25 | 0.60× | 3.86× | ||
| Q3 25 | 0.40× | 2.44× | ||
| Q2 25 | -1.41× | 12.06× | ||
| Q1 25 | -0.31× | 2.50× | ||
| Q4 24 | 0.03× | 3.57× | ||
| Q3 24 | 1.21× | 1.29× | ||
| Q2 24 | 0.68× | 6.45× | ||
| Q1 24 | 2.37× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AAON
| AAON Oklahoma | $215.5M | 51% |
| Bas X | $106.1M | 25% |
| AAON Coil Products | $102.6M | 24% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
